Related Experiment Video
Updated: Jan 13, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Information Deficits, Information Needs, and Preferences Regarding eHealth in a Dutch Population With Metabolic
Sharon Oude Veldhuis1,2, Maureen M J Guichelaar3, Marjolein E M den Ouden1,4
1Research Group Technology, Health & Care, Saxion University of Applied Sciences, M.H. Tromplaan 28, Enschede, 7513 AB, The Netherlands, 088-0198888.
Background:
Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is a common lifestyle-related disease. Lifestyle interventions focusing on healthy eating habits, physical exercise, and reducing body weight in case of obesity are the primary recommended therapies to reverse or improve MASLD. However, patients often experience difficulties in complying with the required lifestyle changes for several reasons, including a lack of knowledge. Health care professionals express limited time during consultations as one of the barriers to discussing lifestyle behavior change. A potential solution to eliminate these barriers and improve the provision of information to patients with MASLD is the use of eHealth.
Objective:
This study aimed to explore the information needs and deficits of patients with MASLD regarding a variety of disease-related topics and their preferences regarding a future eHealth intervention.
Methods:
In a cross-sectional survey study, patients with MASLD were recruited via 2 Dutch patient organizations. The questionnaire included questions on sociodemographics, information provision and needs, and preferences regarding an eHealth intervention. Data were reported using descriptive statistics. Pearson chi-square tests and logistic regression analysis were used to identify differences in outcomes between subgroups.
Results:
The questionnaire was filled out by 449 respondents (women: 363/449, 81%; age: mean 56, SD 11 y). Fewer than 20% of them indicated that they had received sufficient information on a broad range of disease-related topics. Approximately 72% (325/449) to 90% (405/449) of respondents indicated that they would like to receive additional information. Respondents who did not know their disease stage reported a significantly higher need for information on general topics, compared to respondents who reported their disease stage (P values ranging from <.01 to .03). Respondents with (self-reported) metabolic dysfunction-associated steatohepatitis were more interested in contact with fellow patients than respondents with an early or unknown stage of disease (P=.002). Regarding a future eHealth intervention, respondents were most interested in receiving MASLD-related information, practical examples, and references to relevant websites or apps. Respondents were least interested in contact, collaboration, or competition with other app users.
Conclusions:
The vast majority of respondents reported a high rate of information deficits on a broad range of MASLD-related topics and expressed a strong need for additional information. Insights into information needs and preferences regarding eHealth can be used to develop an eHealth intervention for patients with MASLD.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Health Literacy
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

